Ajanta Pharma Limited (NSE:AJANTPHARM)

Ajanta Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 3, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	327,350	280,899	154,878	154,667	155,056	119,225
Market Cap Growth	39.57%	81.37%	0.14%	-0.25%	30.05%	30.84%
Enterprise Value	320,258	276,473	149,016	149,244	150,485	116,768
Last Close Price	2621.15	2210.78	1166.93	1158.85	1141.80	865.27
PE Ratio	36.62	34.42	26.34	21.70	23.71	25.49
Forward PE	31.49	31.03	20.52	19.55	23.58	23.40
PS Ratio	7.25	6.67	4.14	4.63	5.37	4.61
PB Ratio	8.94	7.87	4.57	4.74	5.18	4.59
P/TBV Ratio	9.99	7.91	4.58	4.75	5.20	4.61
P/FCF Ratio	44.40	25.08	37.46	38.31	54.85
P/OCF Ratio	35.78	19.55	27.54	26.91	26.10
PEG Ratio	1.89	1.55	2.89	1.49	1.06	1.29
EV/Sales Ratio	7.07	6.57	3.98	4.47	5.21	4.51
EV/EBITDA Ratio	25.47	23.76	18.74	16.27	15.22	17.50
EV/EBIT Ratio	28.47	26.44	21.92	18.47	16.90	19.87
EV/FCF Ratio	43.70	24.13	36.15	37.18	53.72
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.03
Debt / EBITDA Ratio	0.03	0.03	0.05	0.04	0.04	0.12
Debt / FCF Ratio	-	0.06	0.06	0.08	0.09	0.36
Asset Turnover	-	0.90	0.86	0.85	0.81	0.86
Inventory Turnover	-	1.36	1.38	1.14	1.08	1.48
Quick Ratio	-	1.98	1.71	2.15	1.85	1.80
Current Ratio	-	3.05	2.49	3.50	3.13	2.71
Return on Equity (ROE)	-	23.47%	17.68%	22.77%	23.38%	19.31%
Return on Assets (ROA)	-	14.03%	9.73%	12.89%	15.68%	12.21%
Return on Capital (ROIC)	19.47%	18.59%	12.63%	15.95%	19.49%	14.76%
Return on Capital Employed (ROCE)	-	27.90%	19.20%	23.70%	28.40%	21.70%
Earnings Yield	2.74%	2.91%	3.80%	4.61%	4.22%	3.92%
FCF Yield	2.25%	3.99%	2.67%	2.61%	1.82%
Dividend Yield	2.14%	1.63%	0.60%	0.55%	0.56%	1.00%
Payout Ratio	0.00%	78.68%	15.25%	11.54%	12.68%	24.25%
Buyback Yield / Dilution	0.87%	1.65%	1.19%	0.74%	0.21%	0.85%
Total Shareholder Return	3.01%	3.28%	1.79%	1.28%	0.77%	1.85%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.